pharma news

News

Pig to human kidney transplantation hits a new milestone

A pig kidney transplanted into a human patient has broken records by lasting for nine months, buying time until a human donor organ became available.

News

Viral disease-carrying Aedes mosquito 'breeding in London'

Invasive Aedes mosquitoes and their larvae have been found in London, but the UKHSA says the risk to the public from diseases they can carry is low.

News

AbbVie's cancer TCE etentamig hits the mark in myeloma

AbbVie has reported positive results with CD3xBCMA bispecific etentamig in multiple myeloma, but can it break into a crowded market?

News

Ionis claims first approval for Alexander disease therapy

Ionis' Zanvastro has been approved by the FDA for Alexander disease, becoming the first disease-modifying therapy for the devastating rare disease.

News

Ultragenyx to slash costs after Angelman trial failure

Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.

News

Hutchmed rises on $1.3bn KRAS licensing deal with GSK

GSK has paid Hutchmed $110m upfront for rights to a preclinical KRAS and EGFR-directed drug with potential in colorectal, pancreatic, and lung cancer.

Pig to human kidney transplantation hits a new milestone

Viral disease-carrying Aedes mosquito 'breeding in London'

AbbVie's cancer TCE etentamig hits the mark in myeloma

Ionis claims first approval for Alexander disease therapy

Ultragenyx to slash costs after Angelman trial failure

Hutchmed rises on $1.3bn KRAS licensing deal with GSK

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks